Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Amortizatization of Intangibles (2016 - 2025)

Adma Biologics (ADMA) has disclosed Amortizatization of Intangibles for 13 consecutive years, with $197000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles fell 10.05% year-over-year to $197000.0, compared with a TTM value of $717000.0 through Dec 2025, down 24.61%, and an annual FY2025 reading of $717000.0, down 24.61% over the prior year.
  • Amortizatization of Intangibles was $197000.0 for Q4 2025 at Adma Biologics, up from $170000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $981066.0 in Q3 2022 and bottomed at $160000.0 in Q2 2025.
  • Average Amortizatization of Intangibles over 5 years is $428050.0, with a median of $454075.5 recorded in 2021.
  • The sharpest move saw Amortizatization of Intangibles skyrocketed 101.87% in 2022, then tumbled 68.62% in 2024.
  • Year by year, Amortizatization of Intangibles stood at $502858.0 in 2021, then fell by 1.79% to $493873.0 in 2022, then surged by 41.33% to $698000.0 in 2023, then crashed by 68.62% to $219000.0 in 2024, then fell by 10.05% to $197000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for ADMA at $197000.0 in Q4 2025, $170000.0 in Q3 2025, and $160000.0 in Q2 2025.